# [18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

> **NCT06738862** · — · COMPLETED · sponsor: **Ruijin Hospital** · enrollment: 55 (actual)

## Conditions studied

- α-synucleinopathy
- Parkinson's Disease (PD)
- Multiple System Atrophy
- Rapid Eye Movement Sleep Behavior Disorder
- PET

## Interventions

- **OTHER:** PET

## Key facts

- **NCT ID:** NCT06738862
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-14
- **Primary completion:** 2025-12-25
- **Final completion:** 2025-12-25
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738862, "[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06738862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*